UB-921
UBP-A103-HER2
Phase 1 mab completed
Quick answer
UB-921 for Breast Neoplasm is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Breast Neoplasm
- Phase
- Phase 1
- Modality
- mab
- Status
- completed